Drawing for GLYLEZA

USPTO serial 79286201

GLYLEZA

Reviewed by CopyMark Law Group

Reg. 6172128Status 700Renewal
Filing date
Status date
Registration date
Oct 13, 2020
Examiner
CHANG, ELIZABETH YI HSUAN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GLYLEZA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $425

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthmaACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 3, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 19, 2024CHLDCHANGE OF OWNER RECEIVED FROM IB—
Dec 25, 2020GPNXNOTIFICATION PROCESSED BY IB—
Dec 7, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 7, 2020FIMPFINAL DISPOSITION PROCESSED—
Nov 12, 2020GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Oct 13, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 31, 2020GPNXNOTIFICATION PROCESSED BY IB—
Jul 28, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 15, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 15, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 8, 2020NPUBNOTICE OF PUBLICATION—
Jun 20, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 19, 2020DOCKASSIGNED TO EXAMINER—
Jun 9, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 3, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 2, 2020LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
May 28, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance